医学
沃马克
骨关节炎
双氯芬酸钠
随机对照试验
声带电泳
膝关节痛
可视模拟标度
物理疗法
麻醉
内科学
超声波
药理学
放射科
病理
替代医学
作者
Sena Tolu,Mehmet Köse,M. C. KORKMAZ,Ahmet Üşen,Aylin Rezvanı
出处
期刊:Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca
日期:2021-04-15
卷期号:88 (2): 117-123
被引量:3
标识
DOI:10.55095/achot2021/020
摘要
PURPOSE OF THE STUDYThe objective of the present study is to compare the efficacy of two different concentrations of diclofenac sodium phonophoresis (DSPH) (1.16% vs 2.32%) in patients with knee osteoarthritis (OA). MATERIAL AND METHODSA randomized, double-blind, controlled design was applied.Ninety patients (mean age± SD, 59.98 ± 8.89 years) who had Kellgren-Lawrence (K-L) grades II to III knee OA were randomly allocated into three groups; 1.16% DSPH, 2.32% DSPH, TUS (30 in each group).Each patient was treated five sessions per week for two weeks.A 100-mm visual analogue scale (VAS) for usual pain and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) were evaluated before and after treatment in all groups. RESULTSThe VAS pain and WOMAC scores were significantly improved after treatment in all groups (p < 0.05).The 2.32% DSPH showed more significant effects than the 1.16% DSPH, both in improving WOMAC-pain and physical function scores (p = 0.020, p = 0.008) and reducing the VAS pain measure, although it did not reach the level of significance (p = 0.077).The 2.32% DSPH was superior to the TUS, both in reducing the VAS pain measure (p < 0.001) and in improving WOMAC-pain, stiffness, physical function and total scores (p = 0.022, p = 0.016, p < 0.001, p < 0.001 respectively).1.16% DSPH significantly reduced stiffness and physical function scores compared with TUS (p = 0.042, p = 0.047). CONCLUSIONSDSPH and TUS are effective treatments for knee OA.Our results indicated that 2.32% DSPH produces additional benefits to functional improvement and pain reduction compared with 1.16% DSPH in K-L grades II to III knee OA.
科研通智能强力驱动
Strongly Powered by AbleSci AI